Legal matters
Description:
This handout discusses how a prescribing physician may prepare for a visit from the DEA. Such visits are required by law for physicians prescribing buprenorphine, and involve things such as prescription and dispensing records, and adherence to prescribing limits on number of patients.
Source:
PCSS
Tags:
Description:
The ASI Self-Report Form asks questions about the following topics: your background and employment, your health and family relationships, your legal situation, and your drug and alcohol use.
Source:
Center for Health Care Evaluation (CHCE)
Tags:
Description:
This clinical guidance provides information about the requirements for storing, dispensing, and maintaining records for physicians who provide office-based opioid treatment.
Source:
Physician Clinical Support System (PCSS)
Tags:
Description:
Description of the guidelines that encourage state medical boards to adopt consistent standards in terms of addiction care.
Source:
Federation of State Medical Boards of the United States, Inc
Description:
This 2006 document explains the Drug Enforcement Agency's (DEA) role in regulation of controlled substances and the physician's legal responsibility to prescribe controlled substances for legitimate medical purposes.
Source:
Drug Enforcement Agency (DEA) (3 votes)
Tags:
Description:
This presentation discusses diversion of Subutex® and Suboxone® both in a general sense and in the specific case of the RADARS system, a nonprofit governmental program through the Rocky Mountain Poison and Drug Center.
Source:
Nabarun Dasgupta, MPH (presentation from SAMHSA 2008 Buprenorphine Summit) (3 votes)
Tags:
Description:
This is a basic form that helps physicians keep track of when and what quantity of buprenorphine they dispense.
Source:
American Academy of Addiction Psychiatry (AAAP) (3 votes)
Tags:
Description:
Analyzes the misconceptions that arise from the Health Insurance Portability and Accountability Act and discusses when health care providers should use their professional judgment in deciding whether a disclosure is necessary.
Source:
Journal of the American Medical Association (JAMA) 2005 Apr 13;293(14):1766-71. (3 votes)
Tags:
Description:
This is the full text of Title 21, Chapter 13 of the US Code, which deals with drug abuse prevention and control.
Source:
Drug Enforcement Administration (DEA) (3 votes)
Tags:
Description:
Article describing eight different ways to identify and help drug-seeking patients in your practice.
Source:
Medical Economics (3 votes)
Tags:
